Navigation Links
Medical Marijuana, Inc. Portfolio Company CanChew BioTechnologies Inc. Updates and Expands Free Product Trial
Date:11/20/2012

SAN DIEGO, Nov. 20, 2012 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), a leading hemp industry innovator and its portfolio company CanChew Biotechnologies is pleased to announce that registration for their free product trial of CanChew gum was met with great enthusiasm. 

The offer was originally extended on Oct. 1 to 250 participants, on a first come/first served basis.  It was to include patients suffering from a variety of health issues who would share specific feedback regarding usage and experience. However, due to overwhelming response and a review of regulatory standards, the Company has chosen to reassess its vision for the offer.  It is now focused upon gaining market intelligence for upcoming product offerings. 

Under the updated guidelines, 500 individuals will receive the 30-day free sample of the CBD-based CanChew gum in exchange for their feedback on the appearance, branding and taste of the gum.

Participants can look forward to receiving a minimum one-month supply of the functional CBD gum, which contains approximately 7 milligrams of CBD per piece and will be blister packed in 8 and 32 count packages.  Three different versions of the gum varying in brand, appearance and taste will be randomly distributed and feedback for each specifically tracked. 

Ted Caligiuri, Medical Marijuana, Inc. President, is enthusiastic about this effort.  "We have a tremendous pool of participants for the CanChew free product trial.  The objective feedback they supply on appearance, branding and taste will be invaluable to the development and delivery of a quality product.  It will be instrumental in our preparations for our full blown national CanChew launch in early 2013."

Participants should look for several imminent email updates regarding how to implement their order and shipping.  The only cost involved will be a nominal shipping charge of $4.95 for product delivery. 

All three versions of the gum that participants will receive contain high concentrations of CBD hemp oil and its raw ingredients are derived from the operations of PhytoSphere systems, an MJNA portfolio company.  Medical Marijuana, Inc. anticipates selling these products via the Internet and portfolio company Red Dice Holdings' national distribution platform. Currently, Red Dice Holdings distributes a variety of CBD Hemp oil products in over 500 retail locations throughout Colorado, Arizona, California and New Mexico.

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

For more information, please visit the company's website at: 
www.MedicalMarijuanaInc.com

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration (FDA). These products and statements are not intended to diagnose, treat, cure, or prevent any disease.

Corporate Contact:

Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

Investor Relations Contact:

Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
F. 512-267-2530
Email: ssmith@smallcapvoice.com
Skype: SmallCapVoice.com
AIM: SmallCapVoice7
SOURCE Medical Marijuana, Inc.


'/>"/>
SOURCE Medical Marijuana, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Prostate Cancer Medical Websites: Friend Or Foe?
2. Medical vital-sign monitoring reduced to the size of a postage stamp
3. Arecor Awarded Biomedical Catalyst Funding Towards £1.3 Million Project
4. Creabilis Receives Prestigious Technology Strategy Board Biomedical Catalyst Award
5. Global Medical Image Analysis Software Market Worth $2.4 Billion by 2017
6. Nanofibrillar cellulose film to ease performing medical tests
7. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
8. Germany Prioritizes Medical Biotechnology with New Initiatives
9. University of Kentucky Medical Center Transplants States 1st SynCardia Total Artificial Heart Patient
10. Medical Diagnostic Laboratories, L.L.C. Announces a Complimentary Reflex Test to Determine Azithromycin Resistance in Chlamydia Trachomatis
11. Medical Marijuana, Inc. Portfolio Company PhytoSPHERE Systems Announces Successful Production of Hemp Harvesting for High Value CBD Oil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 09, 2016 , ... There’s a winning streak at Voxx Analytics: the tech ... after winning the award last year as well. Employees nominate their companies for the ... Vesely pointed to the tech company’s upbeat environment as a reason. “We don’t answer ...
(Date:12/9/2016)... ... ... Aditya Humad, Acting CFO of AxioMed and Managing Partner of KICVentures, is pleased ... now gaining interest from Silicon Valley. “It was satisfying to complete the due diligence ... that, “We expect interest to continue to rise as AxioMed completes its cleanroom assembly ...
(Date:12/9/2016)... , Dec. 9, 2016  A platform of ... are moving one step closer to becoming viable ... OrthoMend Research, Inc., a start-up company from ... exclusive license for these novel absorbable bone fixation ... them for commercial use. The company has leased ...
(Date:12/9/2016)... , Dec. 9, 2016 /PRNewswire/ - Portage Biotech ... Exchange: PBT.U), is pleased to announce that Biohaven has ... New Haven, Connecticut (PRWEB) Dec 9, ... or "Biohaven") announced today that the U.S. Food and ... designation request covering its drug candidate BHV-0223, an orally ...
Breaking Biology Technology:
(Date:11/22/2016)... MINNETONKA, Minn. , Nov. 22, 2016   ... that supports the entire spectrum of clinical research, is ... by Medical LiveWire Healthcare and Life Sciences Awards ... This award caps off an unprecedented year of recognition ... clinical trials for over 15 years. iMedNet ...
(Date:11/17/2016)... 2016  AIC announces that it has just released a new white paper authored ... scale-out plus high speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system ...
(Date:11/14/2016)...  xG Technology, Inc. ("xG" or the "Company") (Nasdaq: ... for use in challenging operating environments, announced its results ... will hold a conference call to discuss these results ... (details below). Key Recent Accomplishments ... agreement to acquire Vislink Communication Systems. The purchase is ...
Breaking Biology News(10 mins):